TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) Revenue 2016–2025
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$17.3BFY2025 · since FY2016: $21.9B → $17.3B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $17.3B | +4.3% |
| FY2024 | $16.5B | +4.4% |
| FY2023 | $15.8B | +6.2% |
| FY2022 | $14.9B | -6.0% |
| FY2021 | $15.9B | -4.7% |
| FY2020 | $16.7B | -1.4% |
| FY2019 | $16.9B | -7.6% |
| FY2018 | $18.3B | -16.4% |
| FY2017 | $21.9B | -0.2% |
| FY2016 | $21.9B | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TEVA financial trends
TEVA Net incomeTEVA Net marginTEVA Gross profitTEVA Gross marginTEVA Operating incomeTEVA Operating marginTEVA Operating cash flowTEVA Free cash flowTEVA Capital expendituresTEVA Return on equityTEVA Stock buybacksTEVA Dividends paidTEVA Total assetsTEVA Total liabilitiesTEVA Shareholders’ equityTEVA overview →